
AXA Venture Partners
Investment Thesis
AVP is AXA's venture capital arm investing in high-growth, technology-enabled companies across enterprise software, fintech/insurtech, digital health, consumer technology, and deep tech. Operating multiple funds including a €1.5bn late-growth strategy and €150M early-stage funds, AVP deploys capital ranging from seed to growth stages across Europe, US, Israel, and Canada, with nine-figure check sizes available through its growth vehicles.
Focus Areas
Investment Signals
Sample Portfolio Companies
AUM & Sources
Similar Funds
See incorrect information?
Help us keep this directory accurate and up to date.



